Multicenter Prospective Observational Study of the Comparative Efficacy and Safety of Vancomycin versus Teicoplanin in Patients with Health Care-Associated Methicillin-Resistant Staphylococcus aureus Bacteremia

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2013-10-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.1128/AAC.00520-13PMID 24165181PMCID PMC3910721
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High vancomycin minimum inhibitory concentration and clinical outcomes in adults with methicillin-resistant Staphylococcus aureus infections: a meta-analysis.

  2013influential reference
• The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis.

  2012influential reference
• Influence of teicoplanin MICs on treatment outcomes among patients with teicoplanin-treated methicillin-resistant Staphylococcus aureus bacteraemia: a hospital-based retrospective study.

  2012cited by this paper
• High risk of cross‐reactivity between vancomycin and sequential teicoplanin therapy

  2012cited by this paper
• Empiric guideline-recommended weight-based vancomycin dosing and mortality in methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study

  2012cited by this paper
• Efficacy of linezolid-based salvage therapy compared with glycopeptide-based therapy in patients with persistent methicillin-resistant Staphylococcus aureus bacteremia.

  2012cited by this paper
• Healthcare-associated Staphylococcus aureus bloodstream infection: length of stay, attributable mortality, and additional direct costs.

  2012cited by this paper
• Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary.

  2011cited by this paper
• Comparative efficacy of vancomycin and teicoplanin in the treatment of hospitalised elderly patients with persistent meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia.

  2011influential reference
• Clinical impact of methicillin-resistant Staphylococcus aureus bacteremia based on propensity scores

  2011cited by this paper
• Further Increases in Carbapenem-, Amikacin-, and Fluoroquinolone-Resistant Isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR Study 2009

  2011cited by this paper
• Vancomycin AUC24/MIC Ratio in Patients with Complicated Bacteremia and Infective Endocarditis Due to Methicillin-Resistant Staphylococcus aureus and Its Association with Attributable Mortality during Hospitalization

  2011cited by this paper
• Prediction of Failure in Vancomycin-Treated Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: a Clinically Useful Risk Stratification Tool

  2011cited by this paper
• Teicoplanin versus vancomycin for proven or suspected infection.

  2010cited by this paper
• Risk factors for mortality in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia in a tertiary care hospital in Taiwan.

  2010cited by this paper
• Community-associated meticillin-resistant Staphylococcus aureus.

  2010cited by this paper
• The Sanford guide to antimicrobial therapy

  2010cited by this paper
• Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients.

  2009cited by this paper
• Tolerability of teicoplanin in 117 hospitalized adults with previous vancomycin-induced fever, rash, or neutropenia: a retrospective chart review.

  2009cited by this paper
• Comparative Efficacy and Safety of Vancomycin versus Teicoplanin: Systematic Review and Meta-Analysis

  2009cited by this paper
• Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists.

  2009cited by this paper
• Optimizing Vancomycin Dosing through Pharmacodynamic Assessment Targeting Area under the Concentration-Time Curve/Minimum Inhibitory Concentration

  2009cited by this paper
• What is community-associated methicillin-resistant Staphylococcus aureus?

  2008cited by this paper
• Outcome of patients with meticillin-resistant Staphylococcus aureus bacteraemia at an emergency department of a medical centre in Taiwan

  2008cited by this paper
• CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting.

  2008cited by this paper
• Treatment of infective endocarditis caused by methicillin-resistant Staphylococcus aureus: Teicoplanin versus vancomycin in a retrospective study

  2008cited by this paper
• Community-associated Methicillin-resistant Staphylococcus aureus

  2006cited by this paper
• Harrison's Principles of Internal Medicine 16th ed

  2005cited by this paper
• Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy.

  2004cited by this paper
• Diversity among Community Isolates of Methicillin-Resistant Staphylococcus aureus in Australia

  2004cited by this paper
• Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis.

  2003cited by this paper
• The comparative efficacy and safety of teicoplanin and vancomycin.

  1996cited by this paper
• Comparative Study of Teicoplanin vs Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteraemia

  1996cited by this paper
• The comparative efficacy and safety of teicoplanin and vancomycin.

  1996cited by this paper
• Intracellular activity of both teicoplanin and vancomycin against Staphylococcus aureus in human neutrophils.

  1995cited by this paper
• Validation of a combined comorbidity index.

  1994cited by this paper
• Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy.

  1991cited by this paper
• Harrison's Principles of Internal Medicine

  1988cited by this paper
• Teicoplanin revisited.

  1988cited by this paper
• APACHE II: A severity of disease classification system

  1985cited by this paper
• In vitro activity and human pharmacokinetics of teicoplanin

  1984cited by this paper
• RESEARCH ARTICLE Open Access Research article Nosocomial methicillin-resistant Staphylococcus

  year unknowncited by this paper

• Indole derivatives as antibacterials: overcoming MRSA resistance through SAR insights and AI-driven design

  2026cites this paper
• Comparison of clinical outcomes of antibiotics used for Staphylococcus aureus bacteremia in pediatric patients

  2025cites this paper
• Impact of Vancomycin trough levels monitoring on uncomplicated methilcillin-resistant Staphylococcus aureus bacteremia in chronic kidney disease on hemodialysis, retrospective cohort

  2024cites this paper
• Guidelines for Antibiotics Prescription in Critically Ill Patients

  2024cites this paper
• A retrospective analysis to estimate trough concentrations of teicoplanin in patients with suspected or documented Gram-positive infections

  2023cites this paper
• The Occurrence of Methicillin-Resistant Staphylococcus Aureus (MRSA) Around the World and Antibiotic Therapy for Selected Infections Caused By MRSA

  2023cites this paper
• Population pharmacokinetic analysis and dosing regimen optimization of teicoplanin in critically ill patients with sepsis

  2023cites this paper
• Effectiveness and Safety of Linezolid Versus Vancomycin, Teicoplanin, or Daptomycin against Methicillin-Resistant Staphylococcus aureus Bacteremia: A Systematic Review and Meta-Analysis

  2023cites this paper
• Plasma trough concentration distribution and safety of high‐dose teicoplanin for patients with augmented renal clearance

  2022cites this paper
• Antibiotics for multidrug-resistant gram-positive bacteria

  2022cites this paper
• Impact of vancomycin use trend change due to the availability of alternative antibiotics on the prevalence of Staphylococcus aureus with reduced vancomycin susceptibility: a 14-year retrospective study

  2022cites this paper
• Methicillin Resistant S. aureus (MRSA) Bacteremia: A Case Series and the Clinical Implications of Vancomycin MIC Creep

  2022cites this paper
• Novel Cecropin-4 Derived Peptides against Methicillin-Resistant Staphylococcus aureus

  2021cites this paper
• The Use of Vancomycin Versus Teicoplanin in Treating Febrile Neutropenia: A Meta-Analysis and Systematic Review

  2021cites this paper
• Association between high vancomycin minimum inhibitory concentration and clinical outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: a meta-analysis

  2021cites this paper
• Interlaboratory analysis of teicoplanin plasma concentration assays among Chinese laboratories

  2020cites this paper
• Nephrotoxicity of teicoplanin-based combination therapy: focus on piperacillin/tazobactam and other anti-pseudomonal β-lactams.

  2020cites this paper
• Expert consensus-based clinical practice guidelines management of intravascular catheters in the intensive care unit

  2020cites this paper
• Optimal teicoplanin loading regimen to rapidly achieve target trough plasma concentration in critically ill patients

  2020cites this paper
• Pharmacodynamic comparison of different antimicrobial regimens against Staphylococcus aureus bloodstream infections with elevated vancomycin minimum inhibitory concentration

  2019cites this paper
• COMMUNITY-ACQUIRED PNEUMONIA IN THE INTENSIVE CARE UNIT What are the Common Organisms Causing Community-Acquired Pneumonia in Intensive Care Unit Worldwide and India ?

  2019cites this paper
• Methicillin‐resistant Staphylococcus aureus in solid organ transplantation—Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice

  2019cites this paper
• Bacteriophages Improve Outcome in Experimental Staphylococcus Aureus Ventilator Associated Pneumonia.

  2019cites this paper
• Carriage of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus (MRSA) among students of Jomo Kenyatta University of Agriculture and Technology, Kenya

  2019cites this paper
• Guidelines for Antibiotic Prescription in Intensive Care Unit

  2019cites this paper
• Retrospective analysis of relationships among the dose regimen, trough concentration, efficacy, and safety of teicoplanin in Chinese patients with moderate–severe Gram-positive infections

  2018cites this paper
• Antimicrobial therapy for methicillin-resistant Staphylococcus aureus

  2018cites this paper
• Alternative Treatment of Methicillin Resistant Staphylococcus aureus Infections: An Update

  2018cites this paper
• Diagnosis and treatment of catheter-related bloodstream infection: Clinical guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology and (SEIMC) and the Spanish Society of Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC).

  2018cites this paper
• A Prospective Multicenter Clinical Observational Study on Vancomycin Efficiency and Safety With Therapeutic Drug Monitoring.

  2018cites this paper
• The current role of glycopeptides in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in not neutropenic adults: the viewpoint of a group of Italian experts

  2018cites this paper
• Incidence, prevalence, and management of MRSA bacteremia across patient populations—a review of recent developments in MRSA management and treatment

  2017cites this paper
• Pharmacotherapeutic options for treating Staphylococcus aureus bacteremia

  2017cites this paper
• Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia

  2016cites this paper
• Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia

  2016cites this paper
• Meta-Analysis

  2016cites this paper
• Miscellaneous Antibacterial Drugs

  2016cites this paper
• Daptomycin-loaded static cement spacer: salvage for a failed first-stage revision of a total knee replacement with vancomycin resistance

  2016cites this paper
• Vancomycin, teicoplanin, daptomycin, and linezolid MIC creep in methicillin-resistant Staphylococcus aureus is associated with clonality

  2016cites this paper
• A 5-year survey of antimicrobial susceptibility profiles of methicillin-resistant Staphylococcus aureus (MRSA) isolated from patients with bloodstream infections in Northeast Italy.

  2015cites this paper
• Novel pandemic influenza A (H1N1) and community-associated methicillin-resistant Staphylococcus aureus pneumonia

  2015cites this paper
• UNIVERSITE DU DROIT ET DE LA SANTE - LILLE 2 FACULTE DE MEDECINE HENRI WAREMBOURG Année : 2015

  2015influential citation
• Multidrug-Resistant Gram-Positive Bacterial Infections

  2015cites this paper
• Health care associated infective endocarditis

  2015cites this paper
• Treatment of Methicillin-Resistant Staphylococcus aureus: Vancomycin and Beyond

  2015cites this paper
• Evaluation of Acute Kidney Injury in Pediatric Patients Treated with Vancomycin and Tazobactam/piperacillin Concomitantly: ―A Retrospective Single-center Investigation―@@@―単施設後方視的研究―

  2015cites this paper
• Chapter 26 – Miscellaneous Antibacterial Drugs

  2015cites this paper
• Management of bacterial severe sepsis and septic shock

  2014cites this paper
• Association Between VancomycinMinimum Inhibitory Concentration andMortality Among PatientsWith Staphylococcus aureus Bloodstream Infections

  2014cites this paper
• Association between vancomycin minimum inhibitory concentration and mortality among patients with Staphylococcus aureus bloodstream infections: a systematic review and meta-analysis.

  2014cites this paper
• Clinical management of Staphylococcus aureus bacteremia: a review.

  2014cites this paper